Doonyapat Nguanraksa-Sa

Bangkok, 10700, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

HLA class I-specific nucleolin peptides induce therapeutic T cells in triple-negative breast cancer patients.

HLA class I-specific nucleolin peptides induce therapeutic T cells in triple-negative breast cancer patients.

Journal: International journal of biological sciences

Published: January 30, 2026

Factors associated with physical activity among Thai women with breast cancer postmastectomy at a university hospital, Thailand: A cross-sectional study.

Factors associated with physical activity among Thai women with breast cancer postmastectomy at a university hospital, Thailand: A cross-sectional study.

Journal: Scientific reports

Published: August 03, 2024

Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.

Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.

Journal: BMC medicine

Published: April 18, 2024

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells.

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells.

Journal: Cancer immunology, immunotherapy : CII

Published: October 20, 2023

Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1.

Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1.

Journal: International immunopharmacology

Published: June 01, 2023

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.

Journal: PeerJ

Published: January 13, 2023

Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells.

Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells.

Journal: Oncology reports

Published: March 21, 2022

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer.

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: October 07, 2021

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.

Journal: Oncology reports

Published: July 27, 2021

Expression of long-form prolactin receptor is associated with lower disease-free and overall survival in node-negative breast cancer patients.

Expression of long-form prolactin receptor is associated with lower disease-free and overall survival in node-negative breast cancer patients.

Journal: Gland surgery

Published: February 26, 2021

Filariasis of the breast caused by Brugia pahangi: A concomitant finding with invasive ductal carcinoma.

Filariasis of the breast caused by Brugia pahangi: A concomitant finding with invasive ductal carcinoma.

Journal: Parasitology international

Published: June 21, 2020

A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.

A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients.

Journal: Cancer management and research

Published: April 14, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026